Exelixis Inc (EXEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EXEL | BMY | AMGN | GILD | VRTX |
| Company | Exelixis Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 26.90 | 49.89 | 337.03 | 84.39 | 477.70 |
| High | 27.10 | 50.04 | 338.70 | 84.65 | 483.98 |
| Low | 26.65 | 49.11 | 334.61 | 83.57 | 476.27 |
| Last | 26.97 | 49.60 | 337.29 | 84.15 | 479.85 |
| Change | +0.15 | -0.14 | +4.37 | +0.26 | +5.69 |
| % Change | +0.56% | -0.28% | +1.31% | +0.31% | +1.20% |
| Volume | 1,575,967 | 3,727,496 | 774,973 | 4,714,951 | 478,571 |
| 20-Day Average Volume | 1,495,507 | 8,349,274 | 1,717,040 | 6,476,527 | 963,066 |
| Previous Close | 26.82 | 49.74 | 332.92 | 83.89 | 474.16 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 26.16 | 49.11 | 329.65 | 80.09 | 479.98 |
| 20-Day Raw Stochastic | 69.19% | 67.92% | 90.83% | 93.92% | 49.55% |
| 20-Day Relative Strength | 61.28% | 56.45% | 58.56% | 72.65% | 50.59% |
| Weighted Alpha | +31.47 | -9.97 | +27.73 | +19.03 | +34.47 |
| Today's Opinion | 100% Buy | 72% Buy | 96% Buy | 88% Buy | 56% Buy |
| Previous Opinion | 100% Buy | 72% Buy | 88% Buy | 88% Buy | 40% Buy |
| Last Month's Opinion | 100% Buy | 40% Buy | 88% Buy | 56% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.60% since 09/12/24 | +2.63% since 09/12/24 | +2.15% since 09/12/24 | +1.38% since 09/12/24 | +0.34% since 09/12/24 |
| Low | 26.19 on 09/13/24 | 48.20 on 09/13/24 | 327.15 on 09/13/24 | 81.57 on 09/13/24 | 473.75 on 09/18/24 |
| High | 27.83 on 09/17/24 | 50.41 on 09/17/24 | 339.00 on 09/18/24 | 84.65 on 09/19/24 | 490.15 on 09/16/24 |
| 1-Month | |||||
| %Chg | +1.52% since 08/19/24 | +0.43% since 08/19/24 | +2.80% since 08/19/24 | +13.24% since 08/19/24 | -1.59% since 08/19/24 |
| Low | 25.12 on 09/09/24 | 46.88 on 08/22/24 | 319.00 on 09/06/24 | 74.34 on 08/20/24 | 460.69 on 09/11/24 |
| High | 27.83 on 09/17/24 | 50.75 on 09/04/24 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 500.25 on 08/30/24 |
| 3-Month | |||||
| %Chg | +25.21% since 06/18/24 | +21.32% since 06/18/24 | +10.19% since 06/18/24 | +33.51% since 06/18/24 | +2.78% since 06/18/24 |
| Low | 21.36 on 06/20/24 | 39.35 on 07/05/24 | 303.55 on 06/20/24 | 64.86 on 06/20/24 | 458.04 on 08/13/24 |
| High | 27.83 on 09/17/24 | 51.19 on 07/29/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 |
| 6-Month | |||||
| %Chg | +15.02% since 03/19/24 | -4.42% since 03/19/24 | +24.08% since 03/19/24 | +14.85% since 03/19/24 | +15.68% since 03/19/24 |
| Low | 20.14 on 05/29/24 | 39.35 on 07/05/24 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 391.01 on 04/18/24 |
| High | 27.83 on 09/17/24 | 54.47 on 03/28/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 8,131,825 | 100,827,960 | 178,589,936 | 104,514,608 | 122,358,416 |
| Shares Outstanding, K | 303,200 | 2,027,100 | 536,435 | 1,245,853 | 258,053 |
| Annual Sales | 1,830,210,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | 207,770,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 637,180,000 | 12,201,000,000 | 8,388,000,000 | 6,954,000,000 | 2,645,600,000 |
| Last Quarter Net Income | 226,120,000 | 1,680,000,000 | 746,000,000 | 1,614,000,000 | -3,593,600,000 |
| 60-Month Beta | 0.54 | 0.46 | 0.61 | 0.18 | 0.40 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.84 on 08/06/24 | 2.07 on 07/26/24 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | -12.83 on 08/01/24 |
| Latest Earnings Date | 11/06/24 | 10/31/24 | 10/29/24 | 11/05/24 | 11/04/24 |
| Most Recent Dividend | N/A | 0.600 on 07/05/24 | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A |
| Next Ex-Dividends Date | N/A | 10/04/24 | 08/16/24 | 09/13/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 24.21 | 36.12 | 17.89 | 17.67 | 0.00 |